Awake Nasotracheal Fiberoptic Intubation: A Comparison of Three Techniques of Conscious Sedation with Remifentanil ,Ketamin and Propofol Without Muscle Relaxants .

Clinical Trial of Awake Nasotracheal Fiberoptic Intubation: A Comparison of Three Techniques of Conscious Sedation with Remifentanil ,Ketamin and Propofol Without Muscle Relaxants on hemodynamic Parameters in Tempro-mandibular Joint Ankylosis Surgery

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201208061674N4

Enrollment

Registered

2012-10-15

Start date

2012-11-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Awake Nasotracheal Fiberoptic Intubation in Temporomandibular joint disorders. Ankylosis of joint

Interventions

Intervention 1: Single dose -Intravenous infusion of Remifentanil as "conscious sedation" with dose of 0.75 microgram/kg for fiberoptic intubation through the nose. Intervention 2: Single dose -Intr

Treatment - Drugs

Single dose -Intravenous infusion of Remifentanil as "conscious sedation" with dose of 0.75 microgram/kg for fiberoptic intubation through the nose

Single dose -Intravenous infusion of Ketamin as "conscious sedation" with dose of 0.25 miligram/kg for fiberoptic intubation through the nose

Single dose -Intravenous infusion of Propofol as "conscious sedation" with dose of 0.5 miligram/kg for fiberoptic intubation through the nose

Eligibility

Sex/Gender

All

Age

15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : The patients with Physical status of I and age 15 to 60 years are enrolled; Exclusion criteria : The Patients with systemic disease and or taking any medication will excluded .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hemodynamic stability in cardiovascular patients for safe intubation. Timepoint: During the intubation procedure. Method of measurement: Blood pressure and heart rate monitoring.;Level of sedation and the patient's tolerance to the safe intubation. Timepoint: Immediately before - during - and end of Fiberoptic procedure. Method of measurement: Ramsay Sedation score (RSS).;Speed ??in performing intubation. Timepoint: End of procedure. Method of measurement: minute.	—

Measure

Time frame

Hemodynamic stability in cardiovascular patients for safe intubation. Timepoint: During the intubation procedure. Method of measurement: Blood pressure and heart rate monitoring.;Level of sedation and the patient's tolerance to the safe intubation. Timepoint: Immediately before - during - and end of Fiberoptic procedure. Method of measurement: Ramsay Sedation score (RSS).;Speed ??in performing intubation. Timepoint: End of procedure. Method of measurement: minute.

—

Secondary

Measure	Time frame
Complications during intubation. Timepoint: After the procedure and 24 hours after surgery. Method of measurement: Direct observation by the doctor and the patient report.;Satisfaction of anesthesiologist for intubation. Timepoint: End of the procedure. Method of measurement: Rating of poor (0), moderate (1), good (2), high (3).;Waste of time for procedure. Timepoint: End of the procedure. Method of measurement: minute.	—

Measure

Time frame

Complications during intubation. Timepoint: After the procedure and 24 hours after surgery. Method of measurement: Direct observation by the doctor and the patient report.;Satisfaction of anesthesiologist for intubation. Timepoint: End of the procedure. Method of measurement: Rating of poor (0), moderate (1), good (2), high (3).;Waste of time for procedure. Timepoint: End of the procedure. Method of measurement: minute.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKamal Zarei

Shiraz University of Medical Sciences

paymani@hotmail.com+98 71 1648 3783

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026